EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches

Kevin B Kim iD

Clinical & Experimental Metastasis · 2024

DOI: 10.1007/s10585-024-10291-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical & Experimental Metastasis, 2024. Verfasst von Kevin B Kim. Beteiligte Einrichtung: California Pacific Medical Center Research Institute, 2333 Buchanan St, San Francisco, CA, 94115, USA. kimkb@sutterhealth.org. Hauptthemen laut MEDLINE: Melanoma, Precision Medicine, Molecular Targeted Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent decades, the field of systemic cancer treatment has seen remarkable changes due to advancements in the understanding of cancer's biology, immunology, and genetic makeup. As a result, individuals with late-stage cancers are now achieving survival rates that were previously unattainable. The goal of personalized cancer therapy is to enhance clinical outcomes by customizing drug treatments to suit the unique genetic and/or epigenetic profiles of each patient's tumor. This approach aims to reduce the side effects commonly associated with ineffective treatments. Advances in genetic sequencing and molecular cytogenetics have been instrumental in identifying cancer-driving mutations and epigenetic irregularities, leading to the development of specific molecular therapies. This review article highlights the progress and success of targeted molecular therapies in treating malignant melanoma, illustrating the concept of personalized cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaPrecision MedicineMolecular Targeted TherapyHumansMutationSkin Neoplasms

Stichwörter der Autor:innen

Drug resistance mechanismsGenomicMolecular targeted therapyMutationSignal transduction pathways

Autor:innen und Institutionen

  • California Pacific Medical Center Research Institute, 2333 Buchanan St, San Francisco, CA, 94115, USA. kimkb@sutterhealth.org.

ORCID-Profile: Kevin B Kim

Zitieren

APA

Kim, K. B. (2024). Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches. Clinical & Experimental Metastasis. https://doi.org/10.1007/s10585-024-10291-5

Vancouver

Kim KB. Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches. Clinical & Experimental Metastasis. 2024. doi:10.1007/s10585-024-10291-5

BibTeX
@article{Kim2024,
  author = {Kim, Kevin B},
  title = {Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches},
  journal = {Clinical & Experimental Metastasis},
  year = {2024},
  doi = {10.1007/s10585-024-10291-5}
}
Kostenlos starten →